Multiplex recombinase polymerase amplification for high-risk and low-risk type HPV detection, as potential local use in single tube.
Ontology highlight
ABSTRACT: High rates of new cervical cancer cases and deaths occur in low- and middle-income countries yearly, and one reason was found related to limitation of regular cervical cancer screening in local and low-resource settings. HPV has over 150 types, yet certain 14-20 high-risk and 13-14 low-risk types are common, and, thus, most conventional HPV nucleic acid assays, for examples, Cobas 4800 HPV test (Roche Diagnostics, New Jersey, USA) and REBA HPV-ID (Molecules and Diagnostics, Wonju, Republic of Korea) were developed to cover these types. We thereby utilized bioinformatics combined with recent isothermal amplification technique at 35-42 °C to firstly describe multiplex recombinase polymerase amplification assay that is specific to these common 20 high-risk and 14 low-risk types, and also L1 a
SUBMITTER: Wongsamart R
PROVIDER: S-EPMC9841928 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA